These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 3363529)
1. AT III Barcelona: a familial quantitative-qualitative AT III deficiency. Grau E; Fontcuberta J; Félez J; de Diego I; Soto R; Rutllant ML Thromb Haemost; 1988 Feb; 59(1):13-7. PubMed ID: 3363529 [TBL] [Abstract][Full Text] [Related]
2. Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called ATIII-Barcelona 2. Fontcuberta J; Grau E; Rubio N; Félez J; Rutllant ML Thromb Res; 1988 Jul; 51(1):75-81. PubMed ID: 3413737 [TBL] [Abstract][Full Text] [Related]
3. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto. Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590 [TBL] [Abstract][Full Text] [Related]
4. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity. Howarth DJ; Samson D; Stirling Y; Seghatchian MJ Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307 [TBL] [Abstract][Full Text] [Related]
5. Antithrombin III deficiency. Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A Rom J Intern Med; 1994; 32(2):119-27. PubMed ID: 7920326 [TBL] [Abstract][Full Text] [Related]
6. Antithrombin III molecular variants with defective binding to heparin or to serine proteases: evidence of two different abnormal patterns identified by crossed immunoelectrofocusing. Leone G; De Stefano V; Ferrelli R; Teofili L; Tengborn L; Vahtera E; Bizzi B Thromb Haemost; 1988 Aug; 60(1):8-12. PubMed ID: 3187949 [TBL] [Abstract][Full Text] [Related]
7. Homozygous variant of antithrombin III: AT III Fontainebleau. Boyer C; Wolf M; Vedrenne J; Meyer D; Larrieu MJ Thromb Haemost; 1986 Aug; 56(1):18-22. PubMed ID: 3775688 [TBL] [Abstract][Full Text] [Related]
8. Antithrombin III Alger: a new homozygous AT III variant. Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788 [TBL] [Abstract][Full Text] [Related]
9. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity. de Moerloose PA; Reber G; Vernet P; Minazio P; Bouvier CA Thromb Haemost; 1987 Apr; 57(2):154-7. PubMed ID: 3603409 [TBL] [Abstract][Full Text] [Related]
10. A tentative classification of AT III congenital abnormalities. Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):661-9. PubMed ID: 2448207 [TBL] [Abstract][Full Text] [Related]
11. Two cases of inherited triple deficiency in a large kindred with thrombotic diathesis and deficiencies of antithrombin III, heparin cofactor II, protein C and protein S. Jobin F; Vu L; Lessard M Thromb Haemost; 1991 Sep; 66(3):295-9. PubMed ID: 1836072 [TBL] [Abstract][Full Text] [Related]
12. Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect. De Stefano V; Leone G; De Carolis MP; Ferrelli R; De Carolis S; Pagano L; Tortorolo G; Bizzi B Thromb Haemost; 1987 Jun; 57(3):329-31. PubMed ID: 3660333 [TBL] [Abstract][Full Text] [Related]
13. Inherited antithrombin III deficiency and cerebral thrombosis in a child. Ambruso DR; Jacobson LJ; Hathaway WE Pediatrics; 1980 Jan; 65(1):125-31. PubMed ID: 7355006 [TBL] [Abstract][Full Text] [Related]
14. Antithrombin III Roma: a familial quantitative-qualitative AT-III deficiency identifiable by crossed immunoelectrofocusing and by crossed immunoelectrophoresis. Leone G; Cotumaccio R; De Stefano V; Zanetti L Haematologica; 1983; 68(6):765-74. PubMed ID: 6421671 [No Abstract] [Full Text] [Related]
15. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding. Tripodi A; Krachmalnicoff A; Mannucci PM Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966 [TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding. Jørgensen M; Petersen LC; Thorsen S J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of the "classical" antithrombin III deficiency. Sas G; Petö I; Bánhegyi D; Blaskó G; Domján G Thromb Haemost; 1980 Jun; 43(2):133-6. PubMed ID: 7455972 [TBL] [Abstract][Full Text] [Related]
18. Further characterization of a pathological isoantithrombin with no affinity for heparin (antithrombin III Roma). De Stefano V; Leone G; Ferrelli R; Di Donfrancesco A; De Martini D; Bizzi B Thromb Res; 1987 Oct; 48(1):23-30. PubMed ID: 3424283 [TBL] [Abstract][Full Text] [Related]
19. Antithrombin III Pescara: a defective AT III variant with no alterations of plasma crossed immunoelectrophoresis, but with an abnormal crossed immunoelectrofocusing pattern. Leone G; De Stefano V; Di Donfrancesco A; Ferrelli R; Traisci G; Bizzi B Br J Haematol; 1987 Feb; 65(2):187-91. PubMed ID: 3828226 [TBL] [Abstract][Full Text] [Related]
20. [Antithrombin III. Physiologic, physiopathologic and laboratory aspects]. de Sousa JC; Ferreira R; Carriço F; Nunes V; Geraldes MJ; Parreira F; Ribeiro C Rev Port Cardiol; 1991 Sep; 10(9):693-9. PubMed ID: 1747261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]